Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1340087
European Journal of Endocrinology, Vol 134, Issue 1, 87-92
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wudy, S. A
Right arrow Articles by Teller, W. M
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wudy, S. A
Right arrow Articles by Teller, W. M

5{alpha}-Androstane-3{alpha}, 17β-diol and 5{alpha}-androstane-3{alpha}, 17β-diolglucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study

Stefan A Wudy, Ulrich A Wachter, Janos Homoki and Walter M Teller

Wudy SA. Wachter UA, Homoki J, Teller WM. 5{alpha}-androstane-3{alpha}, 17β-diol and 5{alpha}-androstane-3{alpha}, 17β-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study. Eur J Endrocrinol 1996;134:87–92. ISSN 0804–4643

We investigated the developmental patterns of 5{alpha}-androstane-3{alpha}, 17β-diol (AD) and 5{alpha}-androstane-3{alpha}, 17β-diol-glucuronide (ADG) in plasma of normal children and adults of both sexes and in patients with idiopathic hirsutism using a physicochemical method: high-resolution gas chromatography/ mass spectrometry (HRGC/MS). In children below the age of 11 years, AD and ADG increased with age showing no differences between sexes (mean ±SD nmol/l): normal subjects 3–6 years: AD in females 0.08± 0.03. in males 0.07 ±0.03; ADG in females 0.15 ±0.05, in males 0.14± 0.04: normal subjects 7–10 years: AD in females 0.17 ± 0.03, in males 0.17 ± 0.07; ADG in females 0.59 ± 0.12, in males 0.47 ± 0.14. Thereafter, AD and ADG showed a greater increase in males (normal subjects 11–15 years: AD in females 0.24 ± 0.06, in males 0.41 ±0.14: ADG in females 1.47± 0.36. in males 3.36 ± 1.22). In adults, plasma levels did not overlap between females and males (AD in females 0.24 ±0.07. in males 0.99± 0.31; ADG in females 2.32 ± 0.68, in males 13.01 ± 3.05). 5{alpha}-Androstane-3β, 17β-diol-glucuronide discriminated better between sexes than AD. In idiopathic hirsutism, mean plasma concentrations of AD and ADG were higher than those of healthy females (ages 11–15 years: AD 0.31 ± 0.10. ADG 3.48 ± 2.00; ages > 16 years: AD 0.44 ± 0.27, ADG 6.46 ± 3.11). but 54% of patients had normal plasma concentrations of AD and 29% had normal ADG values. Thus, ADG reflected androgenicity better than AD. However, both metabolites were imperfect markers of androgenicity in idiopathic hirsutism. Therefore, our findings do not support the concept of increased 5{alpha}-reductase activity in all patients with idiopathic hirsutism.

Stefan A Wudy, Steroid Laboratory, First Department of Pediatrics, University of Ulm. D-89070 Ulm/Donau, Germany




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Wudy, H. G. Dörr, C. Solleder, M. Djalali, and J. Homoki
Profiling Steroid Hormones in Amniotic Fluid of Midpregnancy by Routine Stable Isotope Dilution/Gas Chromatography-Mass Spectrometry: Reference Values and Concentrations in Fetuses at Risk for 21-Hydroxylase Deficiency
J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2724 - 2728.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.